MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
property and equipment
$372K
Net cash provided by
(used in) investing...
$372K
Decrease in cash, cash
equivalents and restricted...
-$20,581K
Canceled cashflow
$372K
Deferred revenue
$4,160K
Stock-based compensation
$1,154K
Non-cash operating lease
expense
$859K
Loss on
extinguishment of debt
-$378K
Accounts receivable
-$98K
Depreciation
$83K
Impairment loss on property
and equipment
-$25K
Net cash (used in)
provided by financing...
-$17,761K
Net cash used in
operating activities
-$3,192K
Canceled cashflow
$6,757K
Repayment of debt
$17,729K
Payments under finance
lease obligations
$32K
Net loss
-$7,545K
Operating lease
liabilities
-$976K
Accounts payable
-$530K
Prepaid expenses and
other current assets
$525K
Accrued expenses
-$370K
Other non-cash items
$3K
Back
Back
Cash Flow
source: myfinsight.com
Mersana Therapeutics, Inc. (MRSN)
Mersana Therapeutics, Inc. (MRSN)